CliffBio
small molecule

LUPRON DEPOT

LEUPROLIDE ACETATE

Loss of exclusivity—loss of exclusivity
CompanyABBVIE ENDOCRINE INC

Drug detail

Brand nameLUPRON DEPOT
Active ingredientLEUPROLIDE ACETATE
Strength22.5MG
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalDecember 1995
Marketing statusRX

More from ABBVIE ENDOCRINE INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

LUPRON DEPOT patent cliff — loss of exclusivity — | CliffBio